Does PARITAPREVIR Cause Hepatocellular carcinoma? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Hepatocellular carcinoma have been filed in association with PARITAPREVIR. This represents 7.4% of all adverse event reports for PARITAPREVIR.
15
Reports of Hepatocellular carcinoma with PARITAPREVIR
7.4%
of all PARITAPREVIR reports
4
Deaths
2
Hospitalizations
How Dangerous Is Hepatocellular carcinoma From PARITAPREVIR?
Of the 15 reports, 4 (26.7%) resulted in death, 2 (13.3%) required hospitalization.
Is Hepatocellular carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PARITAPREVIR. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does PARITAPREVIR Cause?
Anaemia (32)
Fatigue (32)
Hyperbilirubinaemia (25)
Headache (19)
Insomnia (19)
Drug interaction (17)
Alanine aminotransferase increased (16)
Hepatic failure (16)
Nausea (16)
Virologic failure (15)
What Other Drugs Cause Hepatocellular carcinoma?
SORAFENIB (1,665)
RIBAVIRIN (1,046)
SOFOSBUVIR (877)
LEDIPASVIR\SOFOSBUVIR (640)
BEVACIZUMAB (532)
REGORAFENIB (470)
DACLATASVIR (419)
ATEZOLIZUMAB (342)
CABOZANTINIB S-MALATE (219)
TACROLIMUS (183)
Which PARITAPREVIR Alternatives Have Lower Hepatocellular carcinoma Risk?
PARITAPREVIR vs PAROXETINE
PARITAPREVIR vs PAROXETINE\PAROXETINE
PARITAPREVIR vs PAROXETINE\PAROXETINE ANHYDROUS
PARITAPREVIR vs PASIREOTIDE
PARITAPREVIR vs PASIREOTIDE DIASPARTATE